Annual FCF
-$33.92 M
-$12.79 M-60.55%
31 December 2023
Summary:
Alto Neuroscience annual free cash flow is currently -$33.92 million, with the most recent change of -$12.79 million (-60.55%) on 31 December 2023. ANRO annual FCF is now -241.16% below its all-time high of -$9.94 million, reached on 01 December 2021.ANRO Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$12.73 M
-$697.00 K-5.79%
30 September 2024
Summary:
Alto Neuroscience quarterly free cash flow is currently -$12.73 million, with the most recent change of -$697.00 thousand (-5.79%) on 30 September 2024. Over the past year, it has dropped by -$4.92 million (-63.05%). ANRO quarterly FCF is now -90.33% below its all-time high of -$6.69 million, reached on 01 June 2023.ANRO Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$47.85 M
-$4.92 M-11.47%
30 September 2024
Summary:
Alto Neuroscience TTM free cash flow is currently -$47.85 million, with the most recent change of -$4.92 million (-11.47%) on 30 September 2024. Over the past year, it has dropped by -$25.81 million (-117.08%). ANRO TTM FCF is now -534.17% below its all-time high of -$7.54 million, reached on 01 March 2023.ANRO TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ANRO Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -60.5% | -63.0% | -117.1% |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
ANRO Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -241.2% | at low | -90.3% | at low | -534.2% | at low |
| 5 y | 5 years | -241.2% | at low | -90.3% | at low | -534.2% | at low |
| alltime | all time | -241.2% | at low | -90.3% | at low | -534.2% | at low |
Alto Neuroscience Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$12.73 M(+5.8%) | -$47.85 M(+11.5%) |
| June 2024 | - | -$12.03 M(+7.4%) | -$42.92 M(+14.2%) |
| Mar 2024 | - | -$11.21 M(-5.6%) | -$37.58 M(+10.8%) |
| Dec 2023 | -$33.92 M | -$11.88 M(+52.1%) | -$33.92 M(+53.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | -$7.81 M(+16.7%) | -$22.04 M(+54.9%) |
| June 2023 | - | -$6.69 M(-11.3%) | -$14.23 M(+88.7%) |
| Mar 2023 | - | -$7.54 M | -$7.54 M |
| Dec 2022 | -$21.13 M(+112.5%) | - | - |
| Dec 2021 | -$9.94 M | - | - |
FAQ
- What is Alto Neuroscience annual free cash flow?
- What is the all time high annual FCF for Alto Neuroscience?
- What is Alto Neuroscience annual FCF year-on-year change?
- What is Alto Neuroscience quarterly free cash flow?
- What is the all time high quarterly FCF for Alto Neuroscience?
- What is Alto Neuroscience quarterly FCF year-on-year change?
- What is Alto Neuroscience TTM free cash flow?
- What is the all time high TTM FCF for Alto Neuroscience?
- What is Alto Neuroscience TTM FCF year-on-year change?
What is Alto Neuroscience annual free cash flow?
The current annual FCF of ANRO is -$33.92 M
What is the all time high annual FCF for Alto Neuroscience?
Alto Neuroscience all-time high annual free cash flow is -$9.94 M
What is Alto Neuroscience annual FCF year-on-year change?
Over the past year, ANRO annual free cash flow has changed by -$12.79 M (-60.55%)
What is Alto Neuroscience quarterly free cash flow?
The current quarterly FCF of ANRO is -$12.73 M
What is the all time high quarterly FCF for Alto Neuroscience?
Alto Neuroscience all-time high quarterly free cash flow is -$6.69 M
What is Alto Neuroscience quarterly FCF year-on-year change?
Over the past year, ANRO quarterly free cash flow has changed by -$4.92 M (-63.05%)
What is Alto Neuroscience TTM free cash flow?
The current TTM FCF of ANRO is -$47.85 M
What is the all time high TTM FCF for Alto Neuroscience?
Alto Neuroscience all-time high TTM free cash flow is -$7.54 M
What is Alto Neuroscience TTM FCF year-on-year change?
Over the past year, ANRO TTM free cash flow has changed by -$25.81 M (-117.08%)